These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3760580

  • 21. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
    Maloney DG, Kaminski MS, Burowski D, Haimovich J, Levy R.
    Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
    [Abstract] [Full Text] [Related]

  • 22. Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma.
    Demanet C, Brissinck J, Leo O, Moser M, Thielemans K.
    Cancer Res; 1994 Jun 01; 54(11):2973-8. PubMed ID: 8187084
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Therapy of lymphoma directed at idiotypes.
    Levy R, Miller RA.
    J Natl Cancer Inst Monogr; 1990 Jun 01; (10):61-8. PubMed ID: 1693283
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Jun 01; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 28. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
    Horton HM, Bernett MJ, Pong E, Peipp M, Karki S, Chu SY, Richards JO, Vostiar I, Joyce PF, Repp R, Desjarlais JR, Zhukovsky EA.
    Cancer Res; 2008 Oct 01; 68(19):8049-57. PubMed ID: 18829563
    [Abstract] [Full Text] [Related]

  • 29. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul 01; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H, Thielemanns K, Tesch H, Engert A, Wolf HJ, van Camp B, Urbain J, Diehl V.
    Cytokines Mol Ther; 1996 Dec 01; 2(4):231-8. PubMed ID: 9384709
    [Abstract] [Full Text] [Related]

  • 34. Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
    Smyth MJ, Bogdanovski M, McKenzie IF, Pietersz GA.
    Cancer Res; 1991 Jan 01; 51(1):310-7. PubMed ID: 1988093
    [Abstract] [Full Text] [Related]

  • 35. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
    Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4556-64. PubMed ID: 17671142
    [Abstract] [Full Text] [Related]

  • 36. Immunotherapy with bispecific antibodies.
    Thielemans KM.
    Verh K Acad Geneeskd Belg; 1995 Aug 01; 57(3):229-47; discussion 247-8. PubMed ID: 7483816
    [Abstract] [Full Text] [Related]

  • 37. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U, Köhler S, Prietl G, Giffels P, Schmidt-Nicolai S, Schlebusch H, Grünn U, Bender H, Biersack HJ, De Potter C, Krebs D, Wallwiener D.
    Zentralbl Gynakol; 1999 Aug 01; 121(4):190-5. PubMed ID: 10355096
    [Abstract] [Full Text] [Related]

  • 38. Anti-idiotypes in B-cell tumor therapy.
    Miller RA, Lowder J, Meeker TC, Brown S, Levy R.
    NCI Monogr; 1987 Aug 01; (3):131-4. PubMed ID: 3493440
    [Abstract] [Full Text] [Related]

  • 39. Development and evaluation of the specificity of a rat monoclonal anti-idiotype antibody, WN, to an anti-B-cell lymphoma monoclonal antibody, LL2.
    Losman MJ, Leung SO, Shih LB, Shevitz J, Shukla R, Haraga L, Goldenberg DM, Hansen HJ.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5978s-5982s. PubMed ID: 7493380
    [Abstract] [Full Text] [Related]

  • 40. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.
    Mohanty K, Saha A, Pal S, Mallick P, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.
    Breast Cancer Res Treat; 2007 Jul 01; 104(1):1-11. PubMed ID: 17004107
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.